Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Adaptive Randomised Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney Pancreas Transplant Recipients

NCT05325008 is registered in ClinicalTrials.gov with The University of Queensland as lead sponsor.

NCT NCT05325008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05325008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Adaptive Randomised Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney Pancreas Transplant Recipients
Lead sponsor
The University of Queensland
Phase
Phase 3
Overall status
Recruiting
Start date
August 18, 2023
Completion date
June 30, 2029
Enrollment
280 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

bk viremia, kidney transplant failure and rejection, kidney transplant infection